- The Epithelial-Immune Crosstalk in Pulmonary Fibrosis
Thomas Planté-Bordeneuve et al, 2021, Frontiers in Immunology CrossRef - Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations
Tihong Shao et al, 2021, Frontiers in Immunology CrossRef - Co-trimoxazole to reduce mortality, transplant, or unplanned hospitalisation in people with moderate to very severe idiopathic pulmonary fibrosis: the EME-TIPAC RCT
Andrew M Wilson et al, 2021, Efficacy and Mechanism Evaluation CrossRef - Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
Anna Valeria Samarelli et al, 2021, International Journal of Molecular Sciences CrossRef - The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases
Jae-Won Lee et al, 2021, Cells CrossRef - Impact of Genetic Variation in TLR4 3′UTR on NSCLC Genetic Susceptibility
Hongjiao Wu et al, 2020, Journal of Oncology CrossRef - Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro
Katja Hattar et al, 2017, Cancer Immunology, Immunotherapy CrossRef - Roles of Toll-Like Receptor 3 in Human Tumors
Xin Zheng et al, 2021, Frontiers in Immunology CrossRef - Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
Jacob E Michalski et al, 2021, Journal of Inflammation Research CrossRef - Research Progress of Prognostic Biomarkers in Idiopathic Pulmonary Fibrosis
静 任, 2022, Advances in Clinical Medicine CrossRef - Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo et al, 2021, Frontiers in Immunology CrossRef - Expression of p16, p53, and TLR9 in HPV-Associated Head and Neck Squamous Cell Carcinoma: Clinicopathological Correlations and Potential Prognostic Significance
Shu Wang et al, 2021, OncoTargets and Therapy CrossRef